[go: up one dir, main page]

AU2013903573A0 - Compositions for the treatment of hypertension and/or fibrosis - Google Patents

Compositions for the treatment of hypertension and/or fibrosis

Info

Publication number
AU2013903573A0
AU2013903573A0 AU2013903573A AU2013903573A AU2013903573A0 AU 2013903573 A0 AU2013903573 A0 AU 2013903573A0 AU 2013903573 A AU2013903573 A AU 2013903573A AU 2013903573 A AU2013903573 A AU 2013903573A AU 2013903573 A0 AU2013903573 A0 AU 2013903573A0
Authority
AU
Australia
Prior art keywords
fibrosis
hypertension
compositions
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2013903573A
Inventor
Karen Annette Duggan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vectus Biosystems Pty Ltd
Original Assignee
Vectus Biosystems Pty Ltd
Filing date
Publication date
Application filed by Vectus Biosystems Pty Ltd filed Critical Vectus Biosystems Pty Ltd
Publication of AU2013903573A0 publication Critical patent/AU2013903573A0/en
Priority to PL14845373T priority Critical patent/PL3046901T3/en
Priority to SG11201601642WA priority patent/SG11201601642WA/en
Priority to JP2016515425A priority patent/JP6122548B2/en
Priority to AU2014324078A priority patent/AU2014324078B2/en
Priority to KR1020167008664A priority patent/KR101736416B1/en
Priority to US15/022,278 priority patent/US9458093B2/en
Priority to NZ717927A priority patent/NZ717927A/en
Priority to ES14845373.1T priority patent/ES2655455T3/en
Priority to DK14845373.1T priority patent/DK3046901T3/en
Priority to CA2924356A priority patent/CA2924356C/en
Priority to NO14845373A priority patent/NO3046901T3/no
Priority to RU2016112257A priority patent/RU2635564C2/en
Priority to EP14845373.1A priority patent/EP3046901B1/en
Priority to BR112016005601-9A priority patent/BR112016005601B1/en
Priority to AP2016009079A priority patent/AP2016009079A0/en
Priority to MX2016003371A priority patent/MX368865B/en
Priority to MYPI2016000482A priority patent/MY172557A/en
Priority to CN201480050979.1A priority patent/CN105683152B/en
Priority to PCT/AU2014/000923 priority patent/WO2015039173A1/en
Priority to UAA201602267A priority patent/UA118111C2/en
Priority to PH12016500497A priority patent/PH12016500497B1/en
Priority to IL244621A priority patent/IL244621A/en
Abandoned legal-status Critical Current

Links

AU2013903573A 2013-09-17 2013-09-17 Compositions for the treatment of hypertension and/or fibrosis Abandoned AU2013903573A0 (en)

Priority Applications (22)

Application Number Priority Date Filing Date Title
UAA201602267A UA118111C2 (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis
RU2016112257A RU2635564C2 (en) 2013-09-17 2014-09-17 Composition for treatment of hypertension and/or fibrosis
NO14845373A NO3046901T3 (en) 2013-09-17 2014-09-17
JP2016515425A JP6122548B2 (en) 2013-09-17 2014-09-17 Composition for the treatment of hypertension and / or fibrosis
AU2014324078A AU2014324078B2 (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis
KR1020167008664A KR101736416B1 (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis
US15/022,278 US9458093B2 (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis
NZ717927A NZ717927A (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis
EP14845373.1A EP3046901B1 (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis
SG11201601642WA SG11201601642WA (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis
CA2924356A CA2924356C (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis
PL14845373T PL3046901T3 (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis
DK14845373.1T DK3046901T3 (en) 2013-09-17 2014-09-17 Compositions for the treatment of high blood pressure and / or fibrosis
ES14845373.1T ES2655455T3 (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and / or fibrosis
BR112016005601-9A BR112016005601B1 (en) 2013-09-17 2014-09-17 compound, pharmaceutical composition, and uses of a compound
AP2016009079A AP2016009079A0 (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis
MX2016003371A MX368865B (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis.
MYPI2016000482A MY172557A (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis
CN201480050979.1A CN105683152B (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis
PCT/AU2014/000923 WO2015039173A1 (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis
PH12016500497A PH12016500497B1 (en) 2013-09-17 2016-03-14 Compositions for the treatment of hypertension and/or fibrosis
IL244621A IL244621A (en) 2013-09-17 2016-03-16 Compositions for the treatment of hypertension and/or fibrosis

Publications (1)

Publication Number Publication Date
AU2013903573A0 true AU2013903573A0 (en) 2013-10-03

Family

ID=

Similar Documents

Publication Publication Date Title
EP3038610A4 (en) Compositions and methods for the treatment of presbyopia
EP2877159B8 (en) Efflux inhibitor compositions and methods of treatment using the same
EP2991658A4 (en) Antimicrobial compositions and methods of making the same
EP3030266A4 (en) Topical compositions and methods of using the same
EP3179983A4 (en) Anti-methanogenic compositions and uses thereof
EP3071215A4 (en) Compositions and methods for treating pulmonary hypertension
EP3102555A4 (en) Compositions of compounds and uses thereof
EP3021839A4 (en) Methods and compositions for treatment of fibrosis
EP3102200A4 (en) Therapeutic compounds and compositions
EP2983681A4 (en) Therapeutic compositions and uses thereof
EP3166892A4 (en) Scale-inhibition compositions and methods of making and using the same
EP3013364A4 (en) Tuberculosis compositions and methods of using the same
EP3004396A4 (en) Methods and compositions for the treatment of cancer
IL244621A0 (en) Compositions for the treatment of hypertension and/or fibrosis
IL244622A0 (en) Compositions for the treatment of hypertension and/or fibrosis
EP3117827A4 (en) Composition for vagina and use of the composition
PL2968478T3 (en) Compositions and methods for the treatment of carboxyhemoglobinemia
EP3165221A4 (en) Blood-fat reducing composition and application thereof
EP3113774A4 (en) Compositions of grapiprant and methods for using the same
EP3068431A4 (en) Methods and compositions for the treatment of hcmv
EP2994147A4 (en) Compositions and methods for the treatment of tinnitus
EP3110435A4 (en) Methods and compositions for the delayed treatment of stroke
EP3038596A4 (en) Compositions and methods for the removal of tattoos
EP3271320A4 (en) Compositions for the treatment of fibrosis and fibrosis-related conditions
EP3294294A4 (en) Compositions and methods for the treatment or prevention of pulmonary hypertension